Answers are grounded in this paper and cite their sources.
Polyacrylamide hydrogel (PAAG), an injectable, jelly-like, medical hydrogel, has been popular in some countries as a non-surgical method of mammoplasty since approximately 2000. Particularly in China, many patients underwent mammoplasty using PAAG during a 16-year period until 2006, and studies on its course and complications were also conducted. However, evidence regarding the relationship between PAAG mammoplasty and malignancy is lacking, and only a few cases have reported the possibility of this association. Herein, we present a case in which malignancy was suspected because of complications 20 years after PAAG injection mammoplasty.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: